Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/22185
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2021-10-01T12:39:02Z-
dc.date.available2021-10-01T12:39:02Z-
dc.date.issued2006-
dc.identifier.citationGökalp, G. ve Topal, U. (2006). ''MR imaging in probably benign lesions (BI-RADS category 3) of the breast''. European Journal of Radiology, 57(3), 436-444.en_US
dc.identifier.issn0720-048X-
dc.identifier.issn1872-7727-
dc.identifier.urihttps://doi.org/10.1016/j.ejrad.2005.10.004-
dc.identifier.urihttp://hdl.handle.net/11452/22185-
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0720048X05003438-
dc.description.abstractPurpose: To investigate the role of dynamic magnetic resonance (MR) imaging in the evaluation of probably benign lesions (BI-RADS category 3) and its contribution to patient management. Materials and methods: Dynamic breast MR imaging was performed in 56 lesions assessed as probably benign in mammography of 43 patients. In MR imaging, T2-weighted turbo spin echo (TSE) with fat suppression sequence followed by pre- and post-contrast T1-weighted 3D-FLASH sequences were used. MR imaging findings were scored using 0-2 point criterion scale. The lesions were divided into five groups according to their total score (0 point: group 1, negative; 1-2 points: group 2, benign; 3 points: group 3, probably benign; 4-5 points: group 4, suspicious for malignancy; 6-8 points: group 5, highly suggestive of malignancy). Histopathologic verification of lesions in group 4 and above was obtained. Lesions in group 3 were either biopsied or followed up by mammography or MR imaging. Lesions in group 1-2 were followed by mammography of 6-month intervals for 2 years. The sensitivity, specificity, accuracy, and positive and negative predictive values of MR imaging in the determination of malignancy in BI-RADS category 3 lesions were calculated. Results: Fifty-six findings (45 mass, 9 breast tissue, 2 focal enhancement) in 43 patients were detected in MR imaging. According to their total score, 41 lesions (73.2%) and breast tissue had 0 point (group 1); 10 lesions (17.8%) had 1-2 points (group 2); 2 lesions (3.6%) had 3 points (group 3); 2 lesions (3.6%) had 4 and 5 points (group 4); and I lesion (1.8%) had 6 points (group 5). Ten lesions (of six in groups I and 2, one in group 3, three in groups 4 and 5) were histopathologically confirmed. Out of 10 lesions, only 1 (1.8%) with 4 points in group 4 was diagnosed as invasive ductal carcinoma. Other lesions followed with mammography or MR imaging did not change. The sensitivity, specificity, accuracy, positive and negative predictive values of MR imaging in the determination of malignancy in BI-RADS category 3 lesions were calculated as 100, 96.4, 96.4, 33.3, and 100%, respectively. Conclusion: In the evaluation of BI-RADS category 3 lesions, dynamic MR imaging does not provide additional information with low positive predictive value similar to that of short interval mammography follow-up.en_US
dc.language.isoenen_US
dc.publisherElsevier Irelanden_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectRadiology, nuclear medicine & medical imagingen_US
dc.subjectProbably benign lesionsen_US
dc.subjectMammographyen_US
dc.subjectBreast MR imagingen_US
dc.subjectBI-RADSen_US
dc.subjectCanceren_US
dc.subjectEnhancementen_US
dc.subjectFeaturesen_US
dc.subjectManagementen_US
dc.subjectMammographic follow-upen_US
dc.subjectTumorsen_US
dc.subjectPatient monitoringen_US
dc.subjectPathologyen_US
dc.subjectMedical imagingen_US
dc.subjectHistologyen_US
dc.subjectBiological organsen_US
dc.subjectMagnetic resonance imagingen_US
dc.subject.meshSensitivity and specificityen_US
dc.subject.meshProspective studiesen_US
dc.subject.meshMammographyen_US
dc.subject.meshMagnetic resonance imagingen_US
dc.subject.meshHumansen_US
dc.subject.meshFemaleen_US
dc.subject.meshBreast neoplasmsen_US
dc.subject.meshBreast diseasesen_US
dc.subject.meshBreasten_US
dc.titleMR imaging in probably benign lesions (BI-RADS category 3) of the breasten_US
dc.typeArticleen_US
dc.identifier.wos000235971000019tr_TR
dc.identifier.scopus2-s2.0-32844462376tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Radyoloji Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0002-3238-9554tr_TR
dc.identifier.startpage436tr_TR
dc.identifier.endpage444tr_TR
dc.identifier.volume57tr_TR
dc.identifier.issue3tr_TR
dc.relation.journalEuropean Journal of Radiologyen_US
dc.contributor.buuauthorGökalp, Gökhan-
dc.contributor.buuauthorTopal, Uğur-
dc.contributor.researcheridAAI-2336-2021tr_TR
dc.identifier.pubmed16316732tr_TR
dc.subject.wosRadiology, nuclear medicine & medical imagingen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubmeden_US
dc.wos.quartileQ3tr_TR
dc.contributor.scopusid8312505100tr_TR
dc.contributor.scopusid57001254100tr_TR
dc.subject.scopusMammography; Breasts; Lobular Carcinomaen_US
dc.subject.emtreeFaten_US
dc.subject.emtreeSensitivity and specificityen_US
dc.subject.emtreeScoring systemen_US
dc.subject.emtreeRadiodiagnosisen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreePatient careen_US
dc.subject.emtreeNuclear magnetic resonance imagingen_US
dc.subject.emtreeMammographyen_US
dc.subject.emtreeInvasive carcinomaen_US
dc.subject.emtreeImage enhancementen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeHistopathologyen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeDiagnostic accuracyen_US
dc.subject.emtreeClinical articleen_US
dc.subject.emtreeCancer diagnosisen_US
dc.subject.emtreeBreast examinationen_US
dc.subject.emtreeBreast canceren_US
dc.subject.emtreeBreast diseaseen_US
dc.subject.emtreeBreast biopsyen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeAgeden_US
dc.subject.emtreeAdulten_US
Appears in Collections:Scopus
Web of Science

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.